We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$802M
AUM Growth
+$26.7M
Cap. Flow
+$2.39M
Cap. Flow %
0.3%
Top 10 Hldgs %
28.66%
Holding
337
New
15
Increased
53
Reduced
138
Closed
9

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$9.04M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$3.38M
3
AMD icon
Advanced Micro Devices
AMD
+$2M
4
TECD
Tech Data Corp
TECD
+$1.52M
5
QCOM icon
Qualcomm
QCOM
+$618K

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$8.72M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.76M
3
TWLO icon
Twilio
TWLO
+$731K
4
UAA icon
Under Armour
UAA
+$709K
5
LUV icon
Southwest Airlines
LUV
+$684K

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Industrials 15.02%
3 Technology 10.52%
4 Financials 9.61%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUV icon
1
Southwest Airlines
LUV
$23.8B
$48.7M 6.07%
869,830
-12,195
-1% -$684K
CELG
2
DELISTED
Celgene Corp
CELG
$37M 4.62%
253,919
-3,180
-1% -$433K
REGN icon
3
Regeneron Pharmaceuticals
REGN
$70.8B
$25M 3.12%
55,899
-281
-0.5% -$134K
AAPL icon
4
Apple
AAPL
$4.81T
$24.9M 3.11%
646,556
-7,020
-1% -$272K
AMGN icon
5
Amgen
AMGN
$198B
$22.5M 2.8%
120,452
-457
-0.4% -$81K
JPM icon
6
JPMorgan Chase
JPM
$918B
$19.7M 2.45%
205,981
-880
-0.4% -$81.2K
META icon
7
Meta Platforms (Facebook)
META
$1.63T
$14.6M 1.83%
85,672
-420
-0.5% -$70.1K
V icon
8
Visa
V
$677B
$14.4M 1.79%
136,814
-175
-0.1% -$17.7K
HON icon
9
Honeywell
HON
$72.8B
$11.7M 1.46%
91,636
-2,140
-2% -$265K
BAC icon
10
Bank of America
BAC
$430B
$11.4M 1.42%
449,094
-9,900
-2% -$240K
BMY icon
11
Bristol-Myers Squibb
BMY
$124B
$11.1M 1.39%
174,805
+3,150
+2% +$184K
PEP icon
12
PepsiCo
PEP
$184B
$11.1M 1.39%
99,889
-1,355
-1% -$157K
JNJ icon
13
Johnson & Johnson
JNJ
$603B
$11.1M 1.39%
85,500
-1,100
-1% -$146K
UNH icon
14
UnitedHealth
UNH
$396B
$11M 1.37%
56,095
-175
-0.3% -$33.8K
DD icon
15
DuPont de Nemours
DD
$18.7B
$10.6M 1.32%
60,318
+54,178
+882% +$9.04M
C icon
16
Citigroup
C
$223B
$9.53M 1.19%
131,059
+900
+0.7% +$61.4K
BA icon
17
Boeing
BA
$161B
$9.35M 1.17%
36,798
-660
-2% -$154K
DIS icon
18
Walt Disney
DIS
$167B
$9.32M 1.16%
94,527
+1,295
+1% +$133K
MSFT icon
19
Microsoft
MSFT
$2.95T
$9.23M 1.15%
123,858
-1,040
-0.8% -$76K
CL icon
20
Colgate-Palmolive
CL
$72.4B
$9.17M 1.14%
125,873
-2,300
-2% -$166K
PG icon
21
Procter & Gamble
PG
$345B
$8.58M 1.07%
94,292
-677
-0.7% -$61.6K
PM icon
22
Philip Morris
PM
$293B
$8.07M 1.01%
72,667
-250
-0.3% -$29.1K
INTC icon
23
Intel
INTC
$530B
$7.86M 0.98%
206,473
+1,017
+0.5% +$36.1K
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.35B
$7.51M 0.94%
199,260
+2,480
+1% +$80.7K
KO icon
25
Coca-Cola
KO
$353B
$7.43M 0.93%
164,982
– –
1
2 3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Gerald L. Ray & Associates held 337 positions worth $802M, up 3.4% from $775M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q3 2017 filing shows 15 new, 53 increased, 138 reduced and 9 closed positions. Its largest new stake was Clovis Oncology, Inc.: 42,630 shares worth $3.51M. The largest sale was Du Pont De Nemours E I, an estimated $8.72M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

  • Gerald L. Ray & Associates's largest Q3 2017 buy was Clovis Oncology, Inc.: 42,630 shares worth $3.51M.
  • Gerald L. Ray & Associates added most to DuPont de Nemours in Q3 2017, an estimated $9.04M increase.
  • Gerald L. Ray & Associates's biggest Q3 2017 reduction was Under Armour, cutting an estimated $709K.
  • Gerald L. Ray & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $8.72M.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $802M portfolio in Q3 2017.
  • Gerald L. Ray & Associates opened 15 new positions and closed 9 in Q3 2017.
  • Gerald L. Ray & Associates's portfolio value rose 3.4% quarter-over-quarter to $802M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.